The English National Risk Reduction Programme for

Preservation of Sight in Diabetes by Gillibrand, Warren P. et al.
Int J Diabetes & Metabolism (2003) 11: 14-29 
14 
Abstracts 
4th International Symposium on Diabetes Mellitus and its Complications: 
From Molecular Biology to Clinical Medicine 
Preston, UK 
____________________________________________________________________________________________________ 
 
Na+/Ca2+ exchange current (INa/Ca) and sarcoplasmic 
reticulum (SR) Ca2+ release in catecholamine-induced 
Cardiac hypertrophy 
 
Alzbeta Chorvatova, George Hart and Munir Hussain 
Department of Medicine, University Clinical Departments, 
University of Liverpool, Liverpool, L69 3GA. 
 
We investigated the effects of cardiac hypertrophy, 
produced by catecholamine administration, on INa/Ca and SR 
Ca2+ release in isolated rat left ventricular myocytes. Steady 
state INa/Ca density, measured using descending  (+80 to –
110 mV) voltage ramps in the whole cell configuration, was 
increased in hypertrophied myocytes (P<0.05). Ca2+ release 
from the SR was also increased, whereas resting [Ca2+]i and 
the rate of decline of [Ca2+]i to control levels were 
unchanged. SR Ca2+content, estimated by using 10.0 
mmol/L caffeine was also significantly increased in 
hypertrophied myocytes, but only when myocytes were held 
and stimulated from their normal resting potential (–80 mV) 
but not from –40 mV. However, the rate of decline of 
caffeine-induced Ca2+ transients or INa/Ca was not 
significantly different between control and hypertrophied 
myocytes. Ca2+-dependence of INa/Ca, examined by 
comparing the slope of the descending phase of the 
hysteresis plots of INa/Ca vs. [Ca2+]i, was also similar in the  
two groups of cells. The observation that increased SR 
function occurred only when myocytes were stimulated 
from –80 mV suggests that Na+ influx may play a role in 
altering Ca2+ homeostasis in hypertrophied cardiac muscle, 
possibly through increased reverse Na+/Ca2+ exchange. 
 
Effect of streptozotocin on insulin and glucagon 
secretion from the  isolated rat pancreas. 
 
Ernest Adeghate and Abdulsamad Ponery 
Department of Anatomy, Faculty of Medicine and Health 
Sciences, United Arab Emirates University, P.O. Box 
17666, Al Ain, United Arab Emirates. 
 
Streptozotocin (STZ) is one of the most commonly used 
agents in studies on experimental diabetes. It was the aim of 
this study to examine the effect of STZ on insulin and 
glucagon secretion from the isolated rat pancreas. 
Pancreatic tissue fragments were incubated with different 
concentrations of STZ for 1 h and the supernatant 
radioimmunoassayed for insulin and glucagon. Stimulation 
of the isolated pancreas with STZ (10-8 –10-4 M)  resulted in 
a dose-dependent increase in insulin secretion. Insulin 
secreted into supernatant (mean ± standard deviation) was 
20.31± 2.05, 37.28 ± 7.99 and 41.94 ± 11.42 µIU L-1 when 
pancreatic tissue fragments were incubated with 10-8 M, 10-6 
M and 10-4 M of STZ respectively. The level of insulin 
secretion obtained with  STZ stimulation at 10-6  and 10-4 M 
were significantly (P < 0.02) higher than that of basal 
(19.83± 5.10 µIU L-1 ). STZ elicited a dose-dependent 
increase in glucagons secretion from the pancreas. 
Glucagon secretion expressed as mean ± standard deviation 
was 184.75 ± 44.44, 205.83 ± 44.30 and 248.01 ± 98.20 pg 
mol -1 , after stimulation with 10-8 M, 10-6 M and 10-4 M of 
STZ, respectively. Glucagon secretion at  10-4 M of  STZ 
was almost a two-fold of that obtained in the basal (156.27 
± 9.52  pg mol -1 ). In summary, STZ can elicit significant 
dose-dependent increases in insulin and glucagons secretion 
from the isolated pancreas.  STZ can thus be regarded as a 
secretagogue of pancreatic hormones.  
 
An update on the aetiology and epidemiology of diabetes 
mellitus 
 
Ernest Adeghate1, Peter Schattner2 and Earl Dunn3 
1Department of Anatomy, Faculty of Medicine and Health 
Sciences, United Arab Emirates University, Al Ain, United 
Arab Emirates and 2Department of Community Medicine 
and General Practice, Monash University, Australia, and 
3Department of Family Medicine, Faculty of Medicine and 
Health Sciences, United Arab Emirates University, Al Ain, 
United Arab Emirates. 
 
Diabetes mellitus is one of the most common endocrine 
disorders affecting almost 6 percent of the world’s 
population. The number of diabetic patients will reach 300 
million in 2025 (International Diabetes Federation, 2001). 
More than 97 % of these patients will have type II diabetes. 
The projected increase in the number of diabetic patients 
will strain the capabilities of health care providers the world 
over. Thus it is of paramount importance to revisit the 
causes and epidemiology of diabetes mellitus. Diabetes 
mellitus is caused by both environmental and genetic 
factors. The environmental factors that may lead to the 
development of diabetes mellitus include physical 
inactivity, drugs and toxic agents, obesity, viral infection 
and location. While Type I diabetes is not a genetically pre-
destined disease, an increased susceptibility can be 
inherited. Genetic susceptibility plays a crucial role in the 
aetiology and manifestation of Type II diabetes with 
concordance in monozygotic twins approaching 100%. 
Genetic factors may have to be modified by environmental 
factors for diabetes mellitus to become overt. An individual 
with a susceptible gene may become diabetic if 
environmental factors modify the expression of these genes. 
Since there is an increase in the trend at which diabetes 
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prevail, it is evident that environmental factors are playing a 
more increasing role in the cause of diabetes mellitus. 
 
The effect of diabetes mellitus on the morphology of the 
heart  
 
Adeghate E  
Department of Anatomy, Faculty of Medicine and Health 
Sciences, United Arab Emirates University, P.O. Box 
17666, Al Ain, United Arab Emirates  
 
Cardiovascular complication is one of the most common 
causes of morbidity and mortality in diabetic patients. The 
mechanisms by which these morphological changes occur 
are poorly understood.  Diabetes mellitus induces abnormal 
changes in the structure of different components of the 
heart. These diabetes-induced morphological changes 
include swelling of mitochondria leading to degeneration in 
the intra-mitochondrial area. Severe diabetes mellitus is also 
associated with disarray of the sarcomere and invagination 
of the nuclear membrane of cardiomyocytes. Some reports 
show a decrease in the volume fraction of myofibrils, 
sarcoplasmic reticulum, T-tubules and cardiomyocyte 
diameter. In diabetes mellitus, the cytoplasm of the 
cardiomyocytes is laden with vacuoles and lipid droplets 
decreasing the effective area of the heart for contractility.  
Diabetes mellitus also affects the cellular components of the 
cardiac interstitium. The quantity of collagen III, IV and VI 
is increased in diabetes. In addition many reports indicate 
that the basement membrane of the endothelium and 
cardiomyocytes are thickened. The pathological changes 
observed in cardiomyocytes and in the interstitial areas of 
the heart may be a result of the accumulation of advanced 
glycation end products in the wall of blood vessels and in 
basement membranes. A number of agents including 
antioxidants and anti-diabetic drugs such as troglitazone 
have been shown to reduce and or reverse these diabetes-
induced morphological changes. 
 
Alterations in Atrial Natriuretic Peptide (ANP) and its 
Receptors in Streptozotocin induced Diabetic Rat 
Kidneys 
 
Abdu Adem1, Ernest  Adeghate2,  Irwin Chandranath1, 
Sheela Benedict3, and Enyioma Obineche3   Departments of 
Pharmacology1 , Anatomy2, and Internal Medicine3, FMHS, 
UAE University, Al Ain, UAE. 
 
The effect of diabetes mellitus on ANP and ANP receptors 
(ANP-R) of streptozotocin (STZ) induced diabetic rat 
kidneys was investigated in this study.  The levels of ANP 
receptors in diabetic and control kidneys were evaluated by 
quantitative receptor autoradiography. Moreover, the 
distribution of ANP in kidney and heart tissues was studied 
by immunohistochemistry. In addition, heart and plasma 
ANP concentration was evaluated in diabetic and control 
rats using radioimmunoassay.  Bodyweight loss was used 
as an index of diabetes mellitus in the STZ rats.  There was 
significant loss in the bodyweight of the diabetic rats 
compared to controls. The efficacy of STZ. administration 
was confirmed by rising blood glucose levels which were 
significantly higher in diabetic rats compared with controls. 
The distribution and levels of ANP-R in diabetic rat 
kidneys and age-matched controls was investigated using 
quantitative receptor autoradiography.Our results 
demonstrate significant decrease in ANP-R in diabetic 
kidneys compared to controls.  The significant decrease 
was found in the juxtaglomerular medulla, inner medulla 
and the papillae.  Intense immunostaining for ANP was 
only observed in the diabetic heart compared to controls. 
Heart  and plasma ANP concentrations were significantly 
greater in the diabetic rats compared to   controls.  The 
increase in heart ANP concentration could be as a result of 
plasma volume expansion present in STZ diabetic rats. This 
increase in heart ANP contributes to the high concentration 
of ANP observed in the plasma. Such increase in plasma 
ANP concentrations may result in the downregulation of 
kidney ANP receptors seen in the diabetic kidney. The 
decrease in ANP receptors observed in the diabetic rat 
kidneys might have pathological consequences resulting in 
renal resistance to ANP in diabetes. 
 
Differential action of hypoglycaemic trace elements on 
gluconeogenesis in kidney-cortex tubules isolated from 
control and diabetic rabbits.   
 
Jadwiga Bryla, Anna Kiersztan, Katarzyna Winiarska, 
Marta Przedlacka, Michal Wegrzynowicz,  
Tomasz Fraczyk. 
Department of Metabolic Regulation, Institute of 
Biochemistry, Warsaw University, Poland. 
 
Derivatives of vanadium, selenium, tungsten and 
molybdenum exhibit insulin-mimetic properties when given 
orally to either diabetic patients or diabetic animals.  The 
action of these trace elements on gluconeogenesis was 
studied in kidney-cortex tubules isolated from control and 
alloxan-diabetic rabbits, which exhibit intracellular 
localization of gluconeogenic enzymes similar to human.   
Gluconeogenic metabolites and oxidized glutathione 
(GSSG) were determined either spectrophotometrically or 
fluorimetrically with the use of specific enzymes, while  
reduced glutathione (GSH) was assayed  by HPLC. The 
mitochondrial membrane potential (∆ϕ) and the cellular 
reactive oxygen species (ROS) were measured 
fluorimetrically with JC-1 and 2’-7’dichlorofluorescein 
diacetate,  respectively.  Rates of gluconeogenesis in renal 
tubules of diabetic rabbits were increased despite 
diminished  ∆ϕ  and the cellular and mitochondrial 
GSH/GSSG ratios.  Vanadyl acetylacetonate (VAc), at 100 
µM concentration, resulted in a marked inhibition of renal 
gluconeogenesis (by about 60-80%), accompanied by 
increased ROS production  and  decreased  ∆ϕ, the cellular 
and mitochondrial GSH/GSSG ratios and glucose-6-
phosphatase activity.  Less pronounced changes in renal 
glucose synthesis, ∆ϕ and the ROS generation were 
observed in the presence of tungstate and molybdate, while 
selenate had no influence. Administration of  2 mM N-
acetylcysteine (NAc) partially attenuated vanadium-induced 
alterations in glucose synthesis, ROS production, ∆ϕ  and 
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cellular GSH/GSSG ratios.  In view of  (i) a  decline in ∆ϕ 
and cellular GSH/GSSG ratios, probably due to increased  
ROS generation, accompanying  inhibitory actions of V, W 
and Mo on renal gluconeogenesis and (ii) a partial reversal 
of the metal-induced changes by NAc, a potential 
therapeutic application of V-, W- and Mo-compounds needs 
a careful evaluation. 
 
Epidemiology of Type 2 Diabetes in Indians 
 
Sangram Jadhav 
Medical Director,  Dr. DY Patil Medical College, Sec 7, 
Nerul, Navi, Mumbai, India 
 
Prevalence of diabetes is increasing globally. India has the 
maximum increase during the last few years. Type 2 
diabetes mellitus is the commonest form of diabetes. The 
prevalence of type 2 diabetes mellitus is 2.4% in rural 
population and 11.6% in urban population. Prevalence of 
impaired glucose tolerance is also high in the urban 
population. Subjects under 40 years of age have a higher 
prevalence of impaired glucose tolerance than diabetes. The 
important risk factors for high prevalence of diabetes 
include: High familial aggregation, obesity especially 
central one, insulin resistance and lifestyle changes due to 
rapid urbanisation. Diabetes Research Centre, carried out 
many studies regarding the risk factors involved in causing 
type 2 diabetes mellitus. The results of these studies are 
mentioned here in this article to have a glimpse of overall 
risk factors involved in causation of diabetes mellitus. 
 
The Prevalence, Type and Severity of Cardiovascular 
Diseases in Diabetic and Non-Diabetic Patients. 
 
Fallows GD and Singh, J 
Department of Biological Sciences, University of Central 
Lancashire, Preston, 
UK and The Department of Cardiology, Victoria Hospital, 
Blackpool, UK. 
 
Introduction: Diabetes mellitus is a major global health 
problem and it affects more than 180 million people 
worldwide. Long-standing diabetic patients are susceptible 
to microvascular and macrovascular disease. Abundant 
evidence shows that patients with either type 1 or type 2 
diabetes are at higher risk for several cardiovascular 
disorders: coronary heart disease, stroke, peripheral arterial 
disease, cardiomyopathy, and congestive heart failure, 
cardiovascular complications are recognised as the leading 
causes of diabetes-related morbidity and mortality. People 
with diabetes have a two to eight fold excess in 
cardiovascular mortality than people without diabetes.   
Aims and Methods : This study  compared 
angiographically-determined cardiovascular disease in 79 
patients with Diabetes Mellitus and an equal number of 
matched controls without diabetes under the age of 55 years. 
 
Seventy-nine diabetic patients coming to coronary 
angiography during a twelve-month period were reviewed 
retrospectively along with 79 control patients matched for 
age (± 3 years), sex, ethnic origin and risk factors 
(hyperlipidemia, body mass index and smoking history). The 
angiographic features of a consecutive series of 62 European 
and 17 Asian patients and their matched-paired controls 
were assessed; all study subjects had undergone elective 
coronary angiography and ventriculography. Angiographic 
findings were graded to describe severity and extent of 
coronary atherosclerosis. Left ventricular systolic function 
was assessed by ejection fraction. Results: The diabetic 
group had a significantly higher arterial systolic pressure 
than the non-diabetic group (p<0.0081) and they were 
clinically obese with a body mass index of >30). Detailed 
analysis of the angiograms showed that prevalence and 
severity of  coronary artery disease in diabetic patients was 
greater, the mean ‘severity score’   was 11.66 for the diabetic 
group against 8.49 for the non-diabetic group (p<0.037), 
multivessel disease was more common in diabetic patients 
than in the controls, with 3-vessel disease being the most 
common. 38 of 79 diabetic patients had 3-vessel disease 
compared to 29 of 79 controls. Diabetic patients were also 
more likely to have more segments diseased in one vessel. 
Systolic function was reduced in the diabetic group, with a 
significantly lower (P<0.035) mean ejection fraction. 
Conclusion :The present study supports the evidence that 
diabetic patients have more extensive coronary artery disease 
than non-diabetic patients and a poorer prognosis, and that 
the coronary arteries of the Asian patients were affected 
more adversely than those of the European group 
irrespective of the diabetic state.  
 
The English National Risk Reduction Programme for 
Preservation of Sight in Diabetes 
 
Warren Gillibrand1, Deborah Broadbent2 Simon Harding3& 
Jiten Vora4. 
1.Member, Policy Advisory Group, National Screening 
Committee, Department of Health, Lecturer: Department of 
Nursing, University of Central Lancashire, Preston, PR1 
2HE, Tel: +44 01772 893775, Fax: +44 01772 892998, E-
mail: wpgillibrand@uclan.ac.uk , 2. Member, Policy 
Advisory Group, National Screening Committee, 
Department of Health, Director: The Liverpool Diabetes 
Eye Centre, Royal Liverpool University Hospital, Rowan 
House, Prescot Street, Liverpool L7 8XP.,  
3. Member, Policy Advisory Group, National Screening 
Committee, Department of Health, Consultant 
Ophthalmologist, St. Pauls Eye Unit, Royal Liverpool 
University Hospital, Prescot Street, Liverpool L7 8XP. ,4. 
Consultant Endocrinologist, Department of Diabetes & 
Endocrinology, Royal Liverpool University Hospital, 
Prescot Street, Liverpool L7 8XP. 
 
Introduction: The National Service Framework for 
Diabetes has set the first target that all people with diabetes 
in England will be screened annually for the detection of 
sight threatening eye disease (STED) by 2007.  There is 
consistent evidence that screening for diabetic retinopathy is 
effective and treatment modalities have been established 
which could prevent partial sight and blindness registration 
in 80-90 % of cases.  Methods:  The Liverpool Diabetic Eye 
Study uses a mobile screening system utilising 35 mm, 
(converting to digital) 3-field fundus photography in all 
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people with diabetes not attending an ophthalmologist.  In 
1995/1996 we reported detection of STED in 7.4% of cases 
compared to a rate of 3.7% in 2001/2002, with a sensitivity 
of 93% and specificity of 94%.  The Policy Advisory Group 
has been formulated with the main aim to establish a cost 
effective national STED screening programme.   There is 
currently inconsistency in service provision for diabetic 
retinopathy screening in the UK, ranging from organised 
services employing cost effective technology to ad hoc 
services with no central organisation.  Two models of 
service delivery are recommended which adhere to the 
National Screening Committee’s requirements for a 
screening programme: diabetic retinopathy screening using 
digital mydriatic retinal photography in both community 
and secondary care settings with image reading by 
accredited individuals; diabetic retinopathy screening using 
indirect slit lamp mydriatic retinal biomicroscopy 
performed by trained personnel in both community and 
secondary care settings. Discussion: Increased funding for 
resources is required in some health authority regions in 
order to establish a screening programme.  It is hoped that 
all people with diabetes will be screened for STED in order 
to reduce the burden of diabetic retinopathy in society. 
 
Effects of volatile anaesthetics on contraction in 
ventricular myocytes from streptozotocin-induced 
diabetic rat 
 
Graham MD, Qureshi MA, Harrison SM, Howarth FC 
 
Various clinically used volatile general anaesthetics (e.g. 
sevoflurane, halothane, isoflurane & desflurane) have been 
shown to have significant inotropic effects on normal 
ventricular muscle (1) however, little is known about their 
effects in ventricular tissue from diabetic animals. 
Streptozotocin (STZ)-induced diabetes is known to induce 
changes in the amplitude and time course of shortening 
(2,3) and one report suggests that the inotropic effects of 
anaesthetics are ameliorated in papillary muscles from 
diabetic animals (4).  The aim of these studies was to 
investigate this further in electrically stimulated (1 Hz) 
ventricular myocytes. Cells were superfused with either 
normal Tyrode (NT) solution or NT containing anaesthetic 
(1 mmol/l) for a period of 2 min (at 30-31 ºC). Myocytes 
from STZ rats were shown to have a significantly longer 
time to peak (P>0.001, n=50) and shortening tended to be 
greater but this was not significant (P = 0.11, n = 50). 
Halothane, isoflurane, desflurane and sevoflurane 
significantly (P<0.05) reduced contraction of control cells 
by 72.5 ± 3.2%, 46.5 ± 9.7%, 28.9 ± 4.3% and 22.8 ± 5.6% 
respectively, (n>12 per group) but their negative inotropic 
effect was found to be no different in cells from STZ-treated 
rats (73.0 ± 4.8%, 40.7 ± 4.7%, 25.0 ± 5.2% and 19.8 ± 
5.2%, respectively) in contrast with previous data (4). 
Therefore, we conclude that the inotropic effects of volatile 
anaesthetics were not altered by STZ-treatment. 
 
1. Davies LA et al, (1999), Brit J Anaes, 82(5): 723-730 
2. Choi KM et al, (2002), Am J Physiol, 283:H1398-H1408 
3. Howarth FC et al, (2002), Pflugers Arch, 444:446-451 
4. Hattori et al, (1987, Anaes Analg, 66: 23-28 
Effects of pressure overload-induced hypertrophy on 
TTX-sensitive inward currents in guinea-pig left 
ventricle  
 
Alzbeta Chorvatova, Richard Snowdon George Hart and 
Munir Hussain 
Department of Medicine, University Clinical Departments, 
University of Liverpool, Liverpool, L69 3GA 
 
We investigated the effects of pressure-overload 
hypertrophy on inward sodium (INa) and calcium currents 
(ICa) in single left ventricular myocytes to determine 
whether changes in these current systems could account for 
the observed prolongation of the action potential. 
Hypertrophy was induced by pressure-overload caused by 
banding of the abdominal aorta. Whole cell patch clamp 
experiments were used to meaasure tetrodotoxin (TTX)-
sensitive inward currents. The main findings were that ICa 
density was unchanged whereas INa density after stepping 
from –80 to –30 mV was decreased by 30% (-9.0 ± 1.16 
pA/pF in control and -6.31 ± 0.67 pA/pF in hypertrophy, 
P<0.05, n=6). Steady-state activation/inactivation variables 
of INa, determined using double-pulse protocols, were 
similair in control and hypertrophied myocytes, whereas the 
time course of fast inactivation of INa was slowed (P<0.05) 
in hypertrophied myocytes. In addition, action potential 
clamp experiments were carried out in the absence and 
presence of TTX under conditions where only Ca2+ was 
likely to enter the cell via TTX-sensitive channels. We show 
for the first time that a TTX-sensitive inward current was 
present during the plateau phase of the action potential in 
hypertrrophied but not control myocytes. The observed 
decrease in INa density is likely to abbreviate rather than 
prolong the action potential. Delayed fast inactivation of 
Na+ channels was not sustained throughout the voltage 
pulse and may therefore merely counteract the effect of 
decreased INa density so that net Na+ influx remains 
unaltered. Changes in the fast INa do not therefore appear to 
contribute to lengthening of the action potential in this 
model of hypertrophy. However, the presence a TTX-
sensitive current during the plateau could potentially 
contribute to prolongation of the action potential in 
hypertrophied cardiac muscle 
 
Enhanced cardiac protein phosphatase activity in type I 
diabetes 
 
Thomas Netticadan 
Institute of Cardiovascular Sciences, St. Boniface Hospital 
Research Centre and University of Manitoba, Canada 
 
Depressed cardiac function has been reported to occur in 
type I diabetes, however the underlying mechanisms are not 
clearly established. Protein phosphorylation and 
dephosphorylation play important roles in regulating cardiac 
function. Because protein phosphatases mediate protein 
dephosphorylation, we hypothesized that cardiac 
dysfunction induced by diabetes will in part be associated 
with alterations in the activities of these enzymes. 
Accordingly, rats were made diabetic by administering a 
single intravenous injection of streptozotocin (65 mg/kg 
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body wt) and cardiac function and protein phosphatase 
activities examined after 1, 2, 3, 4 and 8 weeks. One group 
of 4-week diabetic animals received subcutaneous injection 
of insulin (3U/day) for a further period of 4 weeks. Cardiac 
dysfunction was apparent early on (after 2 weeks of 
induction of diabetes) and deteriorated with time. A 
significant increase in protein phosphatase activity appeared 
very early (after one week) and persisted until 8 weeks. 
Increased protein phosphatase activity was consistent with a 
corresponding increase in the protein contents of protein 
phosphatase 1 and protein phosphatase 2A.  Treatment with 
insulin partly reversed the abnormalities observed in 
diabetic animals. The results of this study suggest that 
increased protein phosphatase activities and therefore 
enhanced protein dephosphoryation may play a role in 
diabetes induced cardiac dysfunction.  
 
Fructose transport and metabolism in adipose tissue of 
Zucker rats: diminished GLUT5 activity during obesity 
and insulin resistance 
 
Gary J. Litherland, Eric Hajduch, Gwyn W. Gould* & 
Harinder S. Hundal 
Division of Molecular Physiology, School of Life Sciences, 
MSI/WTB Complex, The University of Dundee, Dundee 
DD1 5EH U.K. and *Division of Biochemistry and 
Molecular Biology, University of Glasgow, Glasgow, U.K. 
 
Fructose is a major dietary sugar which is elevated in the 
serum of diabetic humans, and is associated with metabolic 
syndromes important in the pathogenesis of diabetic 
complications. The facilitative fructose transporter, GLUT5, 
is expressed in insulin sensitive tissues of humans and 
rodents, where it mediates the uptake of substantial 
quantities of dietary fructose, although little is known about 
its regulation. Here, we present evidence that GLUT5 
expression and activity are compromised severely during 
obesity and insulin resistance in Zucker (fa/fa) rat 
adipocytes. Adipocytes from young (fa/fa), highly insulin-
responsive Zucker rats present considerably more surface 
GLUT5 than those from their lean counterparts (1.8-fold per 
microgram membrane protein), and exhibit higher fructose 
transport (4-fold) and metabolism (3-fold) rates, largely 
directed toward lactate production. As rats age and become 
more obese and insulin-resistant, adipocyte GLUT5 density 
(12-fold) and fructose transport (10-fold) and utilisation 
rates (3-fold) fall markedly. The GLUT5 loss is more 
dramatic in adipocytes from obese animals, which develop a 
more marked insulin resistance than lean counterparts. The 
decline of GLUT5 density in adipocytes from older, obese 
animals does not appear to be a generalised effect, being 
neither shared by the Na+/K+ ATPase, a plasma membrane 
marker, nor observed in kidney. Our findings suggest that 
GLUT5 expression and thus fructose utilisation rates in 
adipocytes are dependent upon cellular insulin sensitivity, 
inferring a significant role for GLUT5 in the elevated 
circulating fructose observed during diabetes, and the likely 
pathological consequences. 
The effects of Type 1 diabetes mellitus on the 
morphology, cytosolic calcium ([Ca2+]i) signals and fatty 
acid lipid profiles in the isolated rat parotid gland. 
 
S. Mahay(a), J. Singh(a), E. Adeghate(b), M.Z. Lindley(a) and 
C.E. Rolph(a). 
(a)Department of Biological Sciences, University of Central 
Lancashire, Preston and (b)Department of Human Anatomy, 
F.M.H.S, United Arab Emirates University, P.O. Box 
17666, Al-Ain, UAE. 
 
Diabetes mellitus (DM) is associated with numerous 
conditions including hypo-secretion of digestive enzymes. 
This study investigates the morphology, [Ca2+]i signals and 
fatty acid lipid profiles in isolated parotid glands of diabetic 
and age-matched control rats in order to understand the 
cellular mechanism of hypo-secretion. The techniques 
employed included light microscopy, fluorimetric and gas 
chromatography analysis (GC), respectively. DM was 
induced in adult male Wistar rats by a single (IP) injection 
of streptozotocin (STZ) (60 mg kg/ body weight). Control 
animals were injected with a similar volume of citrate 
buffer. The animals were tested for DM 4 days after STZ 
injection and 2 months later when they were humanely 
killed for the experiment. The morphological results showed 
diabetic parotid glands to be extensively infiltrated with 
lipid droplets of various magnitudes, whereas glands from 
control animals, display normal structure with the absence 
of lipid droplets. DM produced no significant change in 
either basal or Ach-evoked initial peak  [Ca2+]i signals when 
compared to age-matched control cells. In contrast, DM 
induced a significant (P<0.01) reduction in the plateau 
phase of the [Ca2+]i signal compared to control cells.  Levels 
of fatty acids (16:0, 16:1 and 18:1) in diabetic parotid 
glands were significantly (P<0.01) reduced compared to 
control glands. The results indicate DM can elicit changes 
in the morphology, [Ca2+]i  signals and in fatty acid lipid 
profiles of the isolated rat parotid gland, compared to glands 
from healthy age-matched control rats. 
 
The effect of Vitamin E on metabolic parameters of 
Experimental Diabetes Mellitus 
 
1Al Shamsi MS, 2Amin A and 3Adeghate E 
Department of Graduate Studies, Department of Biology, 
Faculty of Science and Department of Anatomy, Faculty of 
Medicine, United Arab Emirates University, Al Ain, UAE. 
 
The role of vitamin E on Diabetes Mellitus is unknown. The 
purpose of this study was to examine the effect of oral 
administration of vitamin E on some of the metabolic 
effects of experimental diabetic rats. Diabetes was induced 
by intraperitoneal injection of STZ (60 mg/kg body weight 
at 12 weeks of age). Vitamin E (0.2, 0.4, 0.8 mg/Kg body 
weight) was administered orally for a period of three weeks 
to normal and diabetic Wistar rats. In some experiments 
Vitamin E was given either before or after the induction of 
diabetes mellitus. Oral glucose tolerance test (OGTT) were 
performed on fasted normal, diabetic and vitamin E-treated 
rats at the end of the experimental period. Blood sugar level 
and weight were also recorded on a weekly basis for each 
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rat in different groups. Vitamin E significantly (p < 0.01) 
reduced blood sugar level and improved weight gain in 
experimental diabetes mellitus at all doses when compared 
to untreated rats. This beneficial effect of vitamin E on the 
hyperglycaemia of diabetic rats was dose-dependent. 
Moreover, vitamin E also improved OGTT in diabetic rats 
compared to untreated diabetic rats. In conclusion, Vitamin 
E may play a role in insulin metabolism and thus be a useful 
adjuvant therapy in type I diabetes mellitus. 
 
The time course of changes in amine concentrations in 
the rat tail artery following induction of diabetes with 
streptozotocin.   
 
John Morrison, S Dhanasekaran and Rajan Sheen, 
Departments of Physiology and Pharmacology, UAE 
University, Al Ain, UAE  
 
Introduction: We have examined the changes in 
concentrations of noradrenaline, dopamine and serotonin in 
the proximal, middle and distal segments of the rat tail 
artery following the induction of diabetes by injection of 
STZ (60 mgs/kg ip at 10 weeks of age); the present abstract 
is concerned with the time course of the changes from 17.5 
weeks of age to 52 weeks of age.   Tissues were taken under 
pentobarbitone anaesthesia, weighed and treated with 10% 
sodium metabisulphite.  Amines were extracted and 
analysed using HPLC. Results: The control blood glucose 
concentrations were in the range 57 to 68 mgs/dl and the 
diabetic levels were 227 to 380 mgs/dl.  In the control 
animals there was a significant increase in noradrenaline, 
dopamine and serotonin concentrations with age in the 
proximal portion of the tail artery, whereas this was not 
seen in the middle (except in the case of serotonin) and 
distal segments. Between 20 and 30 weeks of age, 
noradrenaline was the most abundant amine, followed by 
serotonin, dopamine and adrenaline.  STZ diabetes resulted 
in major increases in the concentrations of noradrenaline, 
dopamine and serotonin (4-11fold) that generally occurred 
about 16 weeks following the injection of STZ.  The 
maximum increases in amine concentrations occurred in the 
distal segments of the tail artery.  
 
Conclusion: STZ-diabetes is associated with an increase in 
the concentrations of noradrenaline, dopamine and 
serotonin in all segments of the tail artery of the rat.  These 
peak between 10 and 20 weeks following the initial 
treatment. 
 
Biochemical effects of Citrullus colocynthis in non-
diabetic and diabetic rats. 
 
1Al-Ghaithi F, 1El-Ridi M, 2Adeghate E, 1Ameri MH 
1Department of Biology, Faculty of Science, 2Department of 
Anatomy, Faculty of Medicine and Health Science, United 
Arab Emirates University, Al Ain, UAE. 
 
Diabetes mellitus is one of the most common endocrine 
diseases in the world that affects almost 6% of the world 
population (1). In UAE many traditional plants are used as 
anti-diabetic remedies, such as the Citrullus colocynthis 
(Handal). The aim of this study was examine the effect of 
the oral administration of aqueous extract of Citrullus 
colocynthis seeds on biochemical and metabolic parameters 
of normal and streptozotocin (STZ)-induced diabetes rats. 
Diabetes mellitus (DM) was induced by a single 
intraperitoneal (60 mg Kg body wt -1) injection of 
streptozotocin. Normal and diabetic rats were fed with the 
plant extract daily by oral intubations for two weeks. Blood 
sample collected at the beginning and at the end of the 
experiment for measurement of biochemical parameters. 
The plasma level of ALT increased significantly after the 
onset of experimental diabetes. In contrast, the plasma level 
of ALT decreased significantly after the administration of 
the plant extract. All of these results raised and confirm a 
number of interesting issues. Firstly, that STZ has a 
hepatotoxic effect by increasing the plasma level of ALT 
and secondly, the aqueous extract of the C. colocynthis can 
ameliorate the toxic effect of STZ in the liver. Moreover, 
this study suggests that C. colocynthis is not toxic at least 
when given in the higher doses in this study. In diabetic rats 
there was a significant increase in plasma GGT level. This 
elevation is an indicator of hepatotoxicity caused by STZ. 
There were no significant changes in the level of GGT even 
after treating diabetic rats with low and moderate doses of 
the aqueous extract of the plant. There was no significant 
change in the blood level of creatinine, calcium, sodium, 
phosphorus. It is not known why there were no changes in 
these biochemical parameters after treatment with the plant 
extract. It is possible that the concentration of the extract 
may be too weak to have a significant effect or the tissue or 
organ damage may be too severe to show any detectable 
improvement. In conclusion, the results of this study 
revealed that oral administration of the aqueous extract of 
the Citrullus colocynthis can ameliorate the toxic effect of 
STZ.  
Reference 
1.  Adeghate E. Diabetes mellitus: multifactorial in 
aetiology and global in prevalence.    Arch. Physiol. 
Biochem.109: 197-199, 2001. 
 
Increased Incidence of Diabetic Neuropathy on 
Smokers: 9 year Follow Up Result of Sheffield 
Prospective Diabetes Study   
 
S M Rajbhandari (1), LA Scott (2) N D Harris (2) J D 
Ward (2) & S Tesfaye (2) 
Lancashire Teaching Hospital, Chorley & South Ribble, 
PR7 1PP, (2) Diabetes Research Unit, Royal Hallamshire 
Hospital, Sheffield S10 2JF, UK. 
 
Introduction: A number of macrovascular risk factors have 
been associated with the development of diabetic 
neuropathy (DN), however the relation of smoking to DN 
has not been clearly established in a prospective study. 
Aims: The aim of Sheffield Prospective Diabetes study was 
to identify the early abnormalities of clinical, biochemical, 
neurophysiological and haemorrheological functions for the 
development of complications of type 1 diabetes. Materials 
and Methods: 66 newly diagnosed diabetes subjects (mean 
age 31 ± 9 (SD) duration (3 years ± 2) were identified and 
followed up for 9 years. They had detailed smoking history 
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and neurological assessment (symptoms and sign score, 
nerve conduction, vibration perception threshold, warm 
thermal discrimination threshold and cardiac autonomic 
function test) done at baseline and at follow up. Dyck's 
criteria were used to define DN. 9 subjects who had high c-
peptide and 10 subjects who had neuropathy at baseline 
were excluded from the analysis.  Results: Out of 40 
patients followed up at 9 years 7 (17.5%) developed DN of 
which 5 (71%) were smokers at baseline (p <0.0001), which 
was significant after adjusting for the HbA1c. Of the 28 
non-smokers at baseline only 2 (7.1%) developed DN. On 
detail neurophysiological assessment smoking was 
associated with significant (p<0.05) reduction in sural nerve 
conduction and rise in vibration perception threshold. 
Smokers were also likely to develop microalbuminuria 
(p<0.0001) and there was a trend for the development of 
retinopathy (p=0.07) on follow up. Conclusion: This 
prospective study confirms that smoking is a significant risk 
factor for the development of DN and suggests a vascular 
abnormality as its aetiology. Diabetic subjects who smokes 
should be actively encouraged to stop this to prevent both 
macrovascular and microvascular complications. 
 
Protein modifications and apoptosis in Diabetes  
 
Alam Nur-E-Kamal 
Department of Pharmacology, Robert Wood Johnson 
Medical School, University of Medicine and Dentistry of 
New Jersey, 675 Hoes Lane, Piscataway, NJ 08854, U.S.A.  
Phone: (732) 235-0106, Fax: (732) 235-4073, e-mail: 
nurekasa@umdnj.edu 
 
Appropriate regulation of apoptosis has been hypothesized 
to play a key role in the development of diabetes, cancer, 
neuron degeneration, carcinogenesis and aging.  Diabetes 
mellitus is increasing worldwide. It is characterized by 
insulin resistance and a progressive loss of  beta-cell 
function. A current hypothesis is that hyperglycemia might 
be responsible for reduction of the  mass of beta cells by 
inducing apoptosis.  It is our hypothesis that increased 
glucose level causes hyperglycation of the receptor proteins, 
which increase cellular reactive oxygen species (ROS).  
Increased ROS produces DNA damage signals leading to 
apoptosis.  We have produced a system to investigate the 
molecular mechanism of ROS-induced DNA damage 
signaling.  We have observed an increase in ROS-dependent 
protein modification on diabetic and old rats.  We have also 
demonstrated ROS-dependent activation of a DNA damage-
signaling pathway that induces apoptosis of mammalian 
cells in cell culture condition.  Nuclear proteins, ATM and 
p53, are required in transducing DNA damage signals from 
the nucleus to the mitochondria.  The potential role of 
nuclear-mitochondrial signaling in inducing apoptosis in 
diabetes will be discussed. 
 
Diabetes-alcohol interaction:  The effect of alcohol 
treatment during pregnancy on fetal development in 
streptozotocin-induced maternal diabetes in the mouse. 
 
Padmanabhan R and M Shafiulla,   
Faculty of Medicine and Health Sciences, UAE University, 
Al Ain, United Arab Emirates. 
Both maternal diabetes mellitus and alcohol consumption 
during pregnancy have been reported to increase the risk of 
fetal malformations and intrauterine growth alterations 
(IUGR) in the offspring.  But it is not known if alcohol 
interacts with maternal diabetes and what the fetal outcome 
might be if alcohol exposure occurs in diabetic women 
during pregnancy.  Mice were made diabetic by a single 
dose injection (IP) of streptozotocin (STZ) (200 mg/kg) on 
gestation day (GD) 2.  Those with a blood sugar level of 
200 mg/dl or more determined 24 hrs later were regarded as 
diabetics.  They were subsequently injected (IP) on GD 7 or 
8 with a single dose of either 0.003ml/g or 0.03ml/g of 
25%v/v of ethanol in normal saline or a proportionate 
volume of saline alone.  Fetuses were collected on GD 18.  
The diabetic animals consumed more food and water, 
maintained high blood sugar levels throughout pregnancy 
and gained relatively less body weight than the controls.  
Both the STZ and STZ plus ethanol groups of fetuses had 
several craniofacial anomalies such as maxillary-, and 
mandibular hypoplasia, arched palate and consistent growth 
retardation.  A large number of the diabetic group fetuses 
had developed a complex holoprosencephaly sequence 
comprising a proboscis, median eye, mandibular-, maxillary 
agnathia microstomia/astomia, microglossia, cleft palate, 
and extreme reduction in anteroposterior diameter of the 
skull base.  There were considerable inter-individual and 
inter-litter variations in the severity and combinations of 
these anomalies.  Both holoprosencephalic embryos and 
apparently non-malformed embryos had pronounced 
thymus hyoplasia and occasional urogenital malformations.  
The data indicate that both maternal alcohol and diabetes 
act synergistically in inducing malformations and IUGR in 
mouse fetuses. 
(This work was generously supported by the UAE 
University) 
 
Ameliorative effects of α-lipoic acid on maternal 
diabetes-induced growth retardation and malformations 
in rat fetuses.  
 
MHM AL Ghafli, R Padmanabhan, HH Kataya, B Berg 
Faculty of Medicine, UAE University, Al Ain, United Arab 
Emirates.   
 
Background:  Infants of diabetic women have an increased 
incidence of birth defects than those of control population. 
The malformations arise early during development and 
contribute significantly to perinatal mortality and 
morbidity.  Oxidant-antioxidant disequilibrium associated 
with the production of excessive reactive oxygen species 
(ROS) in diabetes may be a contributing factor to fetal 
anomalies.  α-Lipoic acid (LA) has been described as an 
effective antioxidant against a variety of ROS including 
those associated with diabetes.  The objective of the present 
study was to determine the protective effects if any, of LA 
against maternal diabetes-related malformations and 
intrauterine growth retardation (IUGR) in rat fetuses. 
Methods: Pregnant rats were divided into 5 groups: Group 
I was non-treated.  Group II was made diabetic on gestation 
day (GD) 2 by a single intraperitoneal (IP) injection of 
 
 
 21 
 
 
streptozotocin (STZ).  Group III was injected with 20mg/kg 
of LA (IP) daily starting on GD 6 and continued through 
GD 19.  Group IV was administered only Tris buffer on the 
corresponding days.  Group V was STZ-treated but 
followed by a daily dose of 20mg/kg (IP) of LA starting on 
GD 6 and continued through GD 19.  Fetuses were 
collected on GD 20. Results and conclusions: Treatment of 
diabetic rats with LA did not affect their blood sugar levels 
significantly but improved their body weight gain and 
reduced their food and water consumption.  STZ group had 
a manifold increase in embryonic death/resorption, IUGR 
and malformations rate when compared to the control 
groups.  Craniofacial malformations, supernumerary ribs 
and axial and appendicular skeletal hypoplasia were the 
major defects of diabetic group.  Supplementation with LA 
significantly reduced the incidence of fetal death, IUGR, 
malformations, skeletal anomalies and hypoplasia.  
Considering the antioxidant properties of LA, the 
preventative effect of LA on diabetes-associated fetal 
complications suggests that the normal processes of embryo 
survival, growth and development depend on the 
availability of antioxidants.  Our data also support the 
hypothesis that ROS are causally related to fetal 
maldevelopment and IUGR associated with maternal 
diabetes in the rat.   
(This work was generously supported by the UAE 
University) 
 
Investigations into the membrane interactions of m-
calpain, an enzyme implicated in diabetic 
cataractogenesis 
 
David Andrew Phoenix 1, Sarah Dennison 2, Fred Harris 2, 
Thomas Hauβ 3, Silvia Dante 3, Klaus Brandenburg 4 and 
Suman Biswas 5. 
 
1Deans Office, Faculty of Science, University of Central 
Lancashire, Preston, UK 2 Department of Forensic and 
Investigative Science, University of Central Lancashire, 
Preston, UK; 3 Berlin Neutron Scattering Centre, Hahn-
Meitner Institute, 4 Germany. Forschunginstitut, Division of 
Biophysics, Borstel, Germany; 5 Department of 
Ophthalmology, Royal Preston Hospital, Preston, UK. 
 
m-Calpain is a Ca2+ - dependent heterodimeric protease, 
ubiquitous in mammalian cells and recent studies have 
suggested specific activation of the enzyme in diabetic 
caractogenesis. Despite intensive study, the mechanism(s) 
underlying m-calpain activation are not fully understood: In 
vitro activation of the enzyme requires millimolar levels of 
Ca2+, far exceeding those found intra-cellularly, and 
suggesting that in vivo activation of m-calpain involves 
other factors. Lipid has been shown to lower the in vitro 
Ca2+ levels needed to activate the enzyme and we have 
recently predicted that a GTAMRILGGVI segment in 
domain V of the m-calpain smaller subunit will form a lipid 
interactive, oblique orientated α-helix. Here we have tested 
this prediction using VP1, a peptide homologue of the 
GTAMRILGGVI segment, and lipid assemblies mimetic of 
naturally occurring membranes. FTIR conformational 
analysis showed this peptide to be 80% α-helical in the 
presence of DMPC/ DMPS (10:1 molar ratio) vesicles. 
Monolayer studies showed VP1 to induce surface pressure 
changes of 4 mN M–1 in POPC / POPS (10:1 molar ratio) 
monolayers, suggesting interaction with the lipid monolayer 
acyl chain region. Moreover, neutron diffraction studies 
showed VP1 to be localized to the hydrophobic core of 
model POPC / POPS (10:1 molar ratio) bilayer structures, 
consistent with the oblique membrane penetration predicted 
for the peptide. In combination, these results suggest that 
interactions between domain V of m-calpain and lipid / the 
membrane may play a role in the activation of the enzyme. 
 
Voltage dependence of contraction in STZ-induced 
cardiac myocytes  
 
N.K.Bracken, A.J. Woodall and J.Singh) Department of 
Biological Sciences, University of Central Lancashire, 
Preston 
 
It has been reported that diabetic cardiomyopathy is 
associated with increased mortality and morbidity (Schaffer 
(1991) Mol Cell Biochem 107, 1-20). Moreover, it has also 
been reported that hearts from animal models with 
(streptozotocin) STZ-induced type-1 diabetes have altered 
contractility (Choi et al. (2002) Am J Physiol 283, H1398-
H1408). The aim of this study was to ascertain if membrane 
voltage contributes to changes in contraction within the 
diabetic heart. Diabetes was induced in male Wistar rats by 
i.p injection of STZ. Ventricular myocytes were isolated 
according to previously described techniques (Frampton et 
al. (1991). J Physiol 437, 351-375). Patch-clamp recordings 
were made in whole cell, voltage clamp mode using after 
correcting for membrane capacitance, series resistance. 
From a holding potential of –40 mV, test pulses were 
applied at potentials between –30 and + 60 mV in 10 mV 
increments (Howarth FC & Levi AJ (1998). Pflugers Arch 
435, 687-698). ICa,L  and contraction was measured 
simultaneously using a video edge detection system. STZ-
induced diabetes resulted in a significant reduction in body 
and heart weight. Whole blood glucose and plasma 
osmolarity were significantly decreased, while, plasma 
insulin was significantly decreased.  Membrane capacitance 
(pF) was not significantly altered between control (102.7 ± 
5.64 pF, (n=9)) and STZ-induced diabetic myocytes (100.6 
± 2.09 pF,(n=9)). The ICa,L was significantly (P<0.05) 
reduced throughout voltage ranges (0 mV  and +40 mV) in 
STZ-induced  myocytes when compared to age-matched 
controls. Moreover, contraction was significantly (P<0.05) 
greater in control myocytes compared to STZ-induced 
myocytes at all test potentials, however there were no 
significant differences in the time to peak of ICa,L in control 
and STZ-treated myocytes. A decrease in contraction is 
indicative of either reduced SR Ca2+ release or decreased 
myofilament sensitivity to Ca2+. It is suggested that in the 
diabetic heart, a reduction peak ICa,L  leads to decreased SR 
Ca2+ release and a reduction in contraction.  
 
This work was supported by the British Heart foundation 
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Effects of acidosis on contraction and intracellular Ca2+ 
in ventricular myocytes from streptozotocin – induced 
diabetic rat  
 
Singh J, Qureshi MA, Howarth FC 
Department of Physiology, Faculty of Medicine and Health 
Sciences, UAE University, Al Ain, UAE 
 
The concentration of acetoacetic acid, β-hydroxybutyric 
acid and acetone in blood may rise to very high levels in 
diabetic patients and cause metabolic acidosis. The aim of 
this study was to investigate the acute effects of acidosis on 
ventricular myocyte contraction and Ca2+ transport in 
streptozotocin (STZ) - induced diabetic rats. Diabetes was 
induced in rats by i.p. injection of STZ (60 mg kg-1).  
Experiments were performed at 35-36 °C in electrically 
stimulated (1 Hz) ventricular myocytes from control and 
diabetic rats at  8-12 weeks after administration of  
treatment. Characteristics of shortening were measured with 
a video edge detector (VED-114, Crystal Biotech, USA).  
Intracellular Ca2+ was measured in myocytes loaded with 
fura-2/AM. Electrically stimulated myocytes were exposed 
to normal Tyrode solution pH adjusted  to either 7.4 (NT) or 
6.4 (acid NT). The general characteristics of STZ-induced 
diabetes included significant reductions in body and heart 
weight and a 4-fold increase in blood glucose.  Time to peak  
shortening was significantly prolonged in myocytes from 
diabetic compared to control rats. Change of external pH 
from 7.4 to pH 6.4 significantly reduced the amplitude of 
shortening in myocytes from control and diabetic rats 
however, the magnitude of the negative inotropic effects of 
acid NT were not additionally altered by STZ-treatment.  
The amplitude of the Ca2+ transient was also significantly 
reduced by acid NT but the magnitude of the response was 
not additionally altered by STZ-treatment. The acute effects 
of exposure to acid NT on myocyte shortening and Ca2+ 
transient were not significantly altered by STZ-induced 
diabetes.  
 
Does QT dispersion predict the future development of 
cardiac autonomic nephropathy in type 1 diabetes? 
 
S M Rajbhandari (1), L Yeoh (2) N D Harris (2) J D Ward 
(2) & S Tesfaye (2) 
(1) Lancashire Teaching Hospital, Chorley & South 
Ribble, PR7 1PP, (2) Diabetes Research Unit, Royal 
Hallamshire Hospital, Sheffield S10 2JF, UK. 
 
Background: Increased QT dispersion (QTD), the marker 
of cardiac electric heterogeneity has been recognised as a 
marker of sudden cardiac death. In diabetes QTd has been 
suggested to be related to cardiac autonomic neuropathy. 
However there has been no prospective study to show if 
increased QTD leads to future development of cardiac 
autonomic neuropathy. Aim of study:  The aim of this 
study was to analyse if increased QTD at baseline predicts 
the future development of cardiac autonomic neuropathy. 
Merthods: We analysed QTD of 36 subjects who had 
newly diagnosed type 1 diabetes and had ECG performed 
and followed up for 9 years. Cardiac autonomic function 
tests were measured using O-Brien protocol and QTD 
measured from the rate corrected QT interval in ECG after 
magnification. The difference between the longest and 
shortest QTc interval was QTD. The subjects were divided 
into 2 groups by the median value of 71.4ms. Results: 
There was no difference in the age, sex, HbA1 and baseline 
neurophysiological parameters between these two groups. 
After 9 years of follow up there was significant difference 
only in the RR intervals at rest (1.24 ± 0.09 vs 1.18 ± 0.08 
sec (p =0.03) but not during deep breathing ( 1.29 ± 0.13 vs 
1.35 ± 0.16 sec (p = 0.18) with Valsalva (1.71 ± 0.37 vs 
1.81 ± 0.45 sec (p = 0.42) or on standing (1.47 ± 0.25 vs 
1.38 ± 0.20 sec (p=0.35). There were no difference in other 
neurophysiological parameters between these two groups. 
Discussion: Our data suggest that there may not be any 
relation between QT dispersion and development of cardiac 
autonomic neuropathy. 
 
Risk factors other than neuropathy cause increased 
prevalence of high risk feet in newly diagnosed elderly 
type 2 diabetes subjects  
 
H Rathur(1), C Betts(2), S M Rajbhandari(1) 
(1)Lancashire Teaching Hospital, Chorley & South Ribble 
PR7 1PP, (2)Dept of Podiatry, Chorley & South Ribble 
PCT  
 
Background: Chronic complications are often present by 
the time of diagnosis of type 2 diabetes (T2D). However, 
there is paucity of data about various risk factors of foot 
ulceration such as ischaemia, deformity, poor vision etc in 
T2D at the time of diagnosis. Similarly there is little 
information available on characteristics of newly diagnosed 
T2D subjects who are at high risk of developing diabetic 
foot ulcers. Aims of Study: The aim of this study was to 
analyse various risk factors for foot ulceration present in a 
group of newly diagnosed T2D and to identify the sub-
group who are at high risk of developing diabetic foot 
ulcers. Subjects and Method: We have a podiatrist led 
community diabetic foot screening programme and all 
newly diagnosed T2D subjects are screened within 3 
months of diagnosis. We analysed foot screening data of 
292 newly diagnosed T2D subjects and classified them into 
high, medium and low risk categories depending upon 
previous foot ulcers, neuropathy, ischaemia, deformity and 
vision . Results: History of ulcers were present in 4.1%, 
impaired 10gram monofilament sensation in 8.2%, impaired 
pin prick sensation in 20.9% subjects, ischaemia in 26.7%, 
foot deformity in 34.6% and poor vision in 11.1%. 
Increasing age was significantly (p=0.005) related to 'at risk 
feet' with 15% [mean age 66.7 ± 11.9 years] having high 
risk, 29.5% [mean age 66.4 ± 10.6 years] having medium 
risk and 55.5% [mean age 61.6 ± 11.1 years] having low 
risk feet. Age was positively associated with ischaemia 
(p=0.018), deformity (p=0.002), visual problem (P=0.002) 
and living alone (P=0.001) but not with previous ulcers or 
neuropathy. There were no differences in the risk factors 
between males and females. Conclusions: Our data 
confirms the need for foot screening of all newly diagnosed 
T2D subjects with special attention to elderly. 
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To determine incidence of risk factors and complications 
innewly-referred diabetics in the hospital outpatient 
clinic. 
 
S Rajpara , KE Imtiaz  
Department of Diabetes and Endocrinology,  Lancashire 
Teaching Hospital, Chorley, UK  
 
A retrospective analysis of 58 diabetics (37 males, 21 
females) referred to the hospital outpatient diabetes clinic 
from August 2001 to July 2002 was performed. Number of 
type 1 and type 2 diabetics were 9(15.5%) and 49(84.5%) 
respectively. Mean age was ( type 1: 35.4, type 2, 60.3; 
p=0.0001) and duration of diabetes ( type 1,  9.12 ; type 2, 
6.22 ; p=0.0269). 24% of diabetics were current smokers 
while 10% were ex smokers. 82% among this group were 
overweight while 55 %( 24/44) were obese. 65% of patients 
had HbA1c>7 % on initial referral. Mean BP was 140.7/78.9 ( 
type 1 , 125.8/73.2 ; type 2 , 143.4/79.9 ;p=0.0003) ; mean 
cholesterol/HDL ratio: 4.52 ( type 1, 4.27 ; type 2 , 4.56 ; 
p=0.29) and mean triglycerides: 2.3 ( type 1 , 1.73 ; type 2 , 
2.39 ; p=0.1). The incidence of risk factors and complications 
in diabetics was as follows: 
 
Microalbuminuria (52%), Hypertension (48%), ischaemic 
Heart Disease ( IHD, 22% ), peripheral neuropathy (14%), 
cerebrovascular Disease (9%),  retinopathy (7%)  and foot 
ulcers(2%). Only 1 patient had raised serum creatinine (>150 
micromoles per litre) on initial referral. 
 
Type 1 diabetic patients were younger with longer duration of 
diabetes, while type 2 had significantly high blood pressure. 
50 % of all patients were obese and there was high incidence 
of cardiovascular risk factors, e.g.  microalbuminuria , 
hypertension, and ischaemic heart disease.  
 
Audit of risk factor modification and management of 
complications in newly referred diabetic patients to the 
hospital outpatients’ clinic. 
 
S Rajpara, KE Imtiaz. 
Department of Diabetes and Endocrinology, Lancashire 
Teaching Hospital, Chorley, UK 
 
 A retrospective analysis of 58 diabetics (37 males, 21 
females) referred to hospital outpatient diabetes clinic from 
August 2001 to July 2002, was performed. Number of type 
1 and type 2 diabetics  were 9 (15.5%) and 49 (84.5%) 
respectively. All type 1 were on insulin while 51% of type 2 
were on single oral hypoglycaemic drug (OHD) , 24%  on 
diet alone, 20 % on 2 or more OHD, 6%  on combined 
OHD and insulin. 48% of these patients were hypertensive: 
64% receiving ACE inhibitors, 39% calcium channel 
blocker, 32% beta blockers, 29%  diuretics, 21%  
Angiotensin II receptor blocker, 4%  alpha blockers and 
1.9%  centrally acting drugs. Most of these patients required 
combined antihypertensive treatment: 50% (2 drugs) , 
36.2% (3 drugs) and 13.4% ( 4 , >4 ). 13/58 (22%) had 
raised cholesterol/HDL ratio> 5 with only 31% on statins. 
Out of 22 (37.5%) patients with high 
microalbumin/creatinine ratio, only 12/22 (55%) were on 
ACE inhibitors. Only 1 patient had serum creatinine >150 
micromol per litre  and was referred to nephrologist. 85% of 
patients with ischaemic heart disease and 80% with 
cerebrovascular disease were on antiplatelet therapy 
respectively. 7% of patients in our group had retinopathy 
and all were referred to the ophthalmologist. Only 1 patient 
had foot ulcer and was referred to the ulcer clinic. 
Only one-third of eligible patients in our group were 
receiving cholesterol lowering therapy, and only >50 % of 
these were on ACE inhibitors for microalbuminuria. Most 
diabetic patients require a combination of drugs to achieve 
the current target for glycaemia, lipids and blood pressure. 
Aggressive risk factor management is warranted in all 
diabetic patients.  
 
Increased Platelet Activation Predicts the Development 
of Diabetic Neuropathy 
 
S M Rajbhandari (1), LA Scott (2) N D Harris (2) J D 
Ward (2) & S Tesfaye (2) 
(1) Lancashire Teaching Hospital, Chorley & South 
Ribble, PR7 1PP 
(2) Diabetes Research Unit, Royal Hallamshire Hospital, 
Sheffield S10 2JF, UK. 
 
Introduction: The exact pathogenic mechanism of diabetic 
neuropathy (DN) is not fully understood. Cross-sectional 
studies have shown an association between platelet 
activation (PA) and diabetic retinopathy and nephropathy. 
However, the relationship of PA to the development of 
diabetic complications including neuropathy has not been 
studied prospectively. Aims: The aim of this study was to 
examine the association between PA and development of 
microvascular complications including DN in a prospective 
study in a cohort of newly diagnosed type 1 diabetic 
subjects. Methods: We followed 44 newly diagnosed type 1 
diabetic subjects (age 31 +/- 9 [SD] years; duration 3 +/- 2 
years) who underwent detailed neurological assessment and 
plasma β-thromboglobulin (BTG) to assess PA, at baseline, 
3 and 9 years.  Using baseline BTG levels of 25ng/ml as a 
cut-off point, subjects were divided into two groups (18 low 
& 26 high). Results: DN defined as per Dyck's criteria was 
significantly more prevalent in the high BTG group at 9 
years (11.14 % Vs 38.5%; p=0.003). There was no 
difference in peroneal nerve conduction velocity between 
the two groups at baseline and 3 years, but it was 
significantly reduced by 9 years in the high BTG group even 
after the data was adjusted for HbA1c (43.1 +/- 4.5 Vs 37.6 
+/- 5.7 m/sec; p=0.035).  Conclusions: This prospective 
study suggests that platelet activation may have a role in the 
development of DN and hence support the vascular 
dysfunction as a mechanism of DN. 
 
Orally Administered Tryptophan and Experimental 
Type-2 Diabetes. 
 
Tormo MA, Romero de Tejada A, Morales I, Paredes S, 
Sánchez S, Barriga C, Hernández R 
Departamento Fisiología. Facultad de Medicina. 
Universidad de Extremadura. 06071 Badajoz. SPAIN 
 
Introduction: There is a link between diabetes and 
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oxidative stress. Hyperglycaemia leads to free radical 
generation and alterations of endogenous antioxidants. Our 
aim is to study the effect of orally administered L-
tryptophan, the melatonin precursor, an endogenous 
antioxidant, on circulating levels of glycaemia, insulin, and 
melatonin, and on the superoxide dismutase and catalase 
antioxidant systems in non-diabetic (ND) and type-2 
diabetic (neonatal diabetes model: n5-STZ) male Wistar 
rats. Materials and Methods: At 19:30 every day for 15 
days L-tryptophan (TRP: 125 mg/kg b. w.) was 
administered orally. At 09:00 every two days the glycaemia 
was measured and every day the intake of food and water 
was recorded. At the beginning and end of treatment (at 
09:00; 21:00; 02:00) plasma insulin and melatonin levels 
were measured by radioimmunoassay, and (at 09:00) the 
enzymatic activities of catalase (mg/g haemoglobin) and 
superoxide dismutase (SOD, UI/g haemoglobin) in 
erythrocytes by spectrophotometry. The results are 
expressed as mean±SEM (n=6 for each groups).Results: 
Glycaemia values (mmol/L) were greater (p<0.01) in n5-
STZ rats (day 0: 18.74±2.32 and day 15: 22.01±2.99) than 
in ND rats (5.16±0.15 and day 15: 5.49±0.32), while insulin 
levels were lower (p<0.05) at all times studied. These 
parameters were not altered by the TRP administration. 
Melatonin levels (pg/ml) at 02:00 were lower in n5-STZ 
(22.25±11.22) than in ND rats (63.17±19.38; p<0.05). The 
TRP administration did not modify the circulating 
melatonin levels in ND rats, but raised (p<0.01) the levels at 
02:00 in treated n5-STZ rats (56.66±7.17) vs the untreated 
group (8.87±3.29). In ND rats after TRP administration 
there was a decline in catalase activity (day 0: 20.61±0.93; 
day 15: 17.57±1.16; (p<0.05) while in n5-STZ rats there 
was a rise (day 0: 18.69±1.22; day 15: 27.76±2.37; p<0.01). 
After TRP administration there were no significant changes 
in SOD activity or reduction in water intake ml/day in either 
ND or n5-STZ rats, but there was increased food intake 
(g/day) in treated n5-STZ (48.95± 0.79) vs untreated n5-
STZ rats (34.62±1.05; p<0.01). Conclusions: The oral 
administration of L-tryptophan: 1.-did not modify 
glycaemia or insulinaemia levels; 2.- raised melatonin levels 
in diabetic rats at 02:00; 3.- lowered catalase activity in ND 
rats but raised it in n5-STZ rats; 4.-increased food intake in 
n5-STZ rats. This work was financed by the Consejeria de 
Sanidad y Consumo, Junta de Extremadura, Spain. 
 
Beneficial effects of Momordica Charantia fruit juice in 
diabetes mellitus 
 
J.Singh*, A. Sharma, E. Adeghate, I. Ahmed and E. 
Cummings.  Department of Human Anatomy, FMHS, 
United Arab Emirates University, Al-Ain, UAE and 
*Department of Biological Sciences, University of Central 
Lancashire, Preston, England. 
 
Diabetes Mellitus (DM) is a major global health problem 
and diet and exercise play major roles in the management of 
DM.  Prior to insulin therapy, the main form of treatment 
was dietary measures, including the use of traditional 
medicines derived from plants (Platel & Srinivasan, 
Nahrung 41(2), 68-74, 1997).  The fruit juice of one such 
plant is M. charantia (family: Cucurbitacae), which is 
widely used to treat DM.  This study investigates the 
beneficial effect of M. charantia fruit juice in diabetic 
treated rats.  In addition, the effect of the juice on glucose 
transport in L6 muscle cells was also investigated for 
comparison.  Rats were rendered diabetic by a single (I.P) 
injection (60 mg (kg-1 body wt) of streptozotocin (Sharma et 
al, Int. J. Diabetes 4, 29-38, 1996).  One week after 
injection, treated animals were fed with the juice (10 ml kg-
1) daily for 2-3 months.  Body weight, blood pressure, 
glucose levels were measured routinely.  Morphological 
studies were undertaken to confirm diabetes and membrane 
vesicles from jejunum were isolated for the measurement of 
glucose uptake.  Blood glucose concentrations in control, 
diabetic and treated rats ranged from 55 – 64, 414 – 509 and 
350 – 400 mg dl-1 (n=6), respectively.  Insulin 
concentrations in the plasma of normal, diabetic and 
diabetic-treated animals were 5.9 + 0.25, 0.56 U+ 0.37 and 
1.14 + 0.04 ng ml-1 (n=5 animals), respectively.  Similarly, 
the number (mean + SEM, n=5) of insulin-positive cells per 
islet was 22.97 + 3.01 (n=5), 10.97 + 1.23 (n=5) and 16.61 
+ 1.53 (n=5) in control, diabetic and treated diabetic rats, 
respectively.  Systolic blood pressure was 58 + 8.30, 122.8 
+ 19.99 and 91.2 + 14.4 m Hg in normal, diabetic and 
treated rats.  The sodium dependent glucose uptake in brush 
border membrane vesicles isolated from normal, diabetic 
and diabetic treated rat jejunum was (mean + SEM) 428.7 + 
136 (n=6), 1802.3 + 423 (n=6) and 368.6 + 69.2 pmol (mg 
protein)-1, respectively.  In L6 muscle cells, either insulin or 
physiological doses 1-10 µg ml-1 of M. charantia fruit juice 
evoked significant (P<0.05) increases in glucose and amino 
acid uptakes after 1 – 6 hours of incubation compared with 
control.  The results indicate that M. charantia can have 
marked beneficial effects in the treatment of DM. 
 
Secretagogue effect of insulin on pancreatic juice 
secretion in the anaesthetized normal and diabetic rats 
 
M.D. Yago*, J. Singh, M. Mañas*, E. Martinez-Victoria* 
and R. Patel.  Department of Biological Sciences, 
University of Central Lancashire, Preston, UK and 
*Institute of Nutrition, University of Granada, Granada, 
Spain 
 
Insulin is a major metabolic hormone which can regulate 
glucose metabolism.  In the in vitro pancreas, insulin has 
little or no effect on digestive enzyme secretion.  In 
contrast, it can potentiate the secretagogue effects of ACh 
and CCK-8 (Singh et al (1992) Exp. Physiol. 77, 191-202).  
To date, no study has yet investigated the secretagogue 
effect of insulin in the anaesthetized normal and diabetic rat 
preparation.  Animals were rendered diabetic by a single 
injection of streptozotocin (STZ, 60 mg kg-1 I.P.).  Age-
matched controls were injected with an equal volume of 
citrate buffer.  The rats were tested for hyperglycaemia 4 
days after STZ injection and 7 weeks later when they were 
used for the experiments.  Following general anaesthesia (1 
g kg-1 urethane I.P.), laparotomy was performed and the 
pancreatic duct cannulated for the collection of juice using 
established methods (Singh et al, 1992).  After the 
experiments, rats were humanely killed by urethane 
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overdose.  Administration of insulin (1 IU, I.P.) resulted in 
time dependent and significant (P<0.05) increases in 
pancreatic flow rate, protein output and amylase secretion in 
control animals compared to basal secretory parameters.  
Maximal effects occurred after 40 min of insulin 
administration.  The action of insulin was also associated 
with a time dependent decrease in blood glucose levels 
(152.7 + 16.9 mg dl-1 (n=6) prior to insulin and 42.0 + 8.4 
mg dl-1 (n=4) 100 min later).  In diabetic rats insulin (4 IU, 
I.P.) evoked delayed increases in flow, protein output and 
amylase secretion with maximal responses occurring after 
120 min of insulin administration.  Blood glucose level was 
467.6 + 14.0 mg dl-1 (n=10) prior to insulin and this value 
decreased slowly to around 386.6 + 43.6 mg dl-1 (n=7) at 
120 min post-insulin.  The results indicate that insulin can 
evoke marked pancreatic secretagogue effects and stimulate 
glucose metabolism in the healthy rats compared to reduced 
responses in diabetic animals. 
 
Mormordica charantia fruit juice stimulates glucose and 
amino acid uptakes in L6 myotubes.   
 
E. Cummings, H. Hundal*, H. Wackerhage*, N. Woods and 
J. Singh  Department of Biological Sciences, University of 
Central Lancashire, Preston and *Department of 
Physiology, MSI/WTB Complex, University of Dundee, 
Dundee 
 
The fruit of Mormordica Charantia (family: Cucurbitacae) 
is used widely as a hypoglycaemic agent to treat diabetes 
mellitus (DM).  The mechanism of the hypoglycaemic 
action of M. charantia in vitro is not fully understood.  This 
study investigated the effect of M. Charantia juice on either 
3H-deoxy-D-glucose or N-methyl-amino-a-isobutyric acid 
(14C-Me-ATB) uptake in L6 rat muscle cells cultured to the 
myotube stage.  The fresh juice was centrifuged at 5000 
r.p.m and the supernatant lyophilised.  L6 myotubes were 
incubated with different concentrations of either insulin 
(100 nM), the juice (1-10 µg ml-1) or wortmannin (100 nM) 
over a period of 1-6 hours.  Results were expressed as pmol 
min-1 (mg cell protein)-1, n=6-8 for each value.  Basal 3H-
deoxy-D-glucose and 14C-Me-ATB uptakes by L6 myotubes 
after 1h of incubation were (means+ SEM) 32.14 + 1.34 and 
13.48 + 1.86, respectively.  Incubation of L6 myotubes with 
100 nM insulin for 1 h resulted in significant (ANOVA, 
P<0.05) increases in 3H-deoxy-D-glucose and 14C-Me-ATB 
uptakes.  Typically, 3H-deoxy-D-glucose and 14C-Me-ATB 
uptakes in the presence of insulin were 58.57 + 4.49 and 
29.52 + 3.41, respectively.  Incubation of L6 myotubes with 
three different concentrations (1, 5 and 10 µg ml-1) of the 
lyophilised juice resulted in time-dependent increases in 3H-
deoxy-D-glucose and 14C-Me-ATB uptakes, with maximal 
uptakes occurring at a concentration of 5 µg ml-1.  
Incubation of either insulin or the juice in the presence of 
wortmannin (a phosphatidyl inositol 3-kinase inhibitor) 
resulted in a marked inhibition of 3H-deoxy-D-glucose by 
L6 myotubes compared to the uptake obtained with either 
insulin or the juice alone.  The results indicate that M. 
charantia fruit juice is acting like insulin to exert its 
hypoglycaemic effect. 
Role of phospholipid signaling in diabetes-induced 
defective cardiomyocyte contractile activity.  
 
Paramjit S. Tappia.  
Institute of Cardiovascular Sciences, St. Boniface Hospital 
Research Centre and the Department of Human Nutritional 
Sciences, University of Manitoba, Winnipeg, Canada. 
 
This study was conducted to investigate the effects of 
phosphatidic acid (PA), a known inotropic agent, on Ca2+ 
transients and contractile activity of cardiomyocytes 
isolated from chronic streptozotocin-induced diabetic rats.  
In control cells, PA induced a significant increase in active 
cell shortening (25%) and Ca2+ transients (40%).  Maximal 
effects were found with 25µM PA. Inhibition of 
phospholipase C (PLC) with NCDC, blocked the positive 
inotropic action induced by PA. Consistent with this effect, 
PA increased inositol 1,4,5-trisphosphate (IP3) generation in 
the control cardiomyocytes.  Furthermore, the PA-induced 
increase in contractile activity was attenuated by treatment 
of cardiomyocytes with thapsigargin as well as with 
nicardipine. Conversely, in cardiomyocytes from diabetic 
rats, PA-induced a 25% decrease in active cell shortening 
and no significant effect on Ca2+ transients. Basal and PA 
induced IP3 generation in diabetic rat cardiomyocytes was 3 
fold lower as compared to control cells, which was 
associated with an impaired sarcolemmal membrane PLC 
δ1 activity as well as its attenuated response to PA. Insulin 
treatment of the diabetic animals resulted in a partial 
recovery of PA responses. Our results, therefore, identify an 
important defect in the PA-PLC signaling pathway in 
diabetic rat cardiomyocytes, which may have implications 
for heart dysfunction during diabetes. 
 
Mechanism of pancreatic insufficiency in streptozotocin-
induced diabetes mellitus.   
 
R. Patel*, J. Singh*, E. Martinez-Victoria#, M. Mañas# and 
M.D. Yago#.   
*Department of Biological Sciences, University of Central 
Lancashire, Preston and #Institute of Nutrition and Food 
Technology, University of Granada, Granada, Spain. 
 
Exocrine pancreatic insufficiency is a major long term 
complication in diabetes mellitus and very little is known 
about the mechanism of this symptom.  This study 
investigated the effects of cholecystokinin-octapeptide 
(CCK-8) on pancreatic juice flow and its contents, and on 
cytosolic calcium (Ca2+) and magnesium (Mg2+) levels in 
the diabetic rats compared to age-matched control.  Animals 
were rendered diabetic by a single injection of 
streptozotocin (60 mg kg-1, I.P).  Age-matched control rats 
obtained an equivalent volume of citrate buffer.  Seven 
weeks later, animals were either anaesthetized (1g kg-1 
urethane; I.P) for the measurement of pancreatic juice flow 
or humanely killed and the pancreas isolated for the 
measurements of cytosolic Ca2+ and Mg2+ levels.  Non-
fasting blood glucose levels in control and diabetic rats 
were 92.40 + 2.42 mg dl-1 (n=8) and >500 mg dl-1 (n=10), 
respectively.  Resting (basal) pancreatic juice flow in 
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control and diabetic anaesthetized rats was 0.49 + 0.04 ul 
min-1 (n=10) and 1.17 + 0.09 ul min-1 (n=11).  CCK-8 
infusion resulted in a significant (P<0.05) increase in 
pancreatic juice flow in control animals compared to a 
much larger increase in diabetic rats.  In contrast, CCK-8 
evoked significant (P<0.05) increases in protein output and 
amylase secretion in control rats compared to much reduced 
responses in diabetic animals.  Basal [Ca2+]i in control and 
diabetic fura-2-loaded acinar cells was 109.40 + 15.41 nM 
(n=15) and 130.62 + 17.66 nM (n=8), respectively.  CCK-8 
(10-8 M) induced a peak response of 436.55 + 36.54 nM 
(n=15) and 409.31 + 34.64 nM (n=8) in control and diabetic 
cells.  Basal [Mg2+]i in control and diabetic magfura-2-
loaded acinar cells was 1.00 + 0.06 nM (n=18) and 0.88 + 
0.04 nM ( n=10).  In the presence of CCK-8 (10-8) [Mg2+]i 
in control and diabetic cells was 0.80 + 0.05 nM (n=18) and 
0.60 + 0.02 nM (n=10), respectively.  The results indicate 
that diabetes-induced pancreatic insufficiency may be 
associated with derangements in cellular Ca2+ and Mg2+ 
homeostasis. 
 
Comparison of diabetes care between category B and 
category C prison 
 
 K Wright, F Rathur, S M Rajbhandari 
 Lancashire Teaching Hospital, Chorley,  PR7 1PP, UK 
 
Introduction: The management of diabetes in prison can be 
difficult, as  inmates have limited freedom on diet, exercise 
and access to external health care. We extended care to 
inmates by regular visit of diabetes specialist nurse to local 
prisons and train prison nurses. To assess the effect, we  
analysed the diabetes annual review prisoners received. 
Aims: The aims of  this study was to find out the quality of 
diabetes annual review care  inmates received in prison and 
to compare the care between two prisons.  Results: Data on 
13 male subjects [mean age ± (SD) 50.2 ± 14.3 years] in  
category B prison were compared with 8 male subjects 
[mean age 53 ± 9.5   years] in category C prison. In B 
prison 46.1% subjects were on insulin,  38.5% on oral 
hypoglycaemics and 15.4% on diet alone and in C prison it 
was   12.5%, 75% and 12.5%. Screening for retinopathy and 
feet were arranged in   100% and 46.1% in B prison and 
87.5% and 62.5% in C prison. Blood pressure   control in 
both prisons was similar and none had developed 
nephropathy.   There were no differences in HbA1c (7.97 ± 
2.26 vs 7.7 ± 1.21; p =0.9) or   cholesterol (5.05 ± 1.07 vs 
5.52 ± 1.5; p = 0.9) between these prisons.   Conclusion: 
Our data suggest that good diabetes care can be provided to 
prison inmates and the category of prison does not affect 
this. 
 
Halothane inhibits contraction and calcium mobilization 
in streptozotocin-induced diabetic rat ventricular 
myocytes.  
 
A.Woodall*, J.Singh*, F.C. Howarth# & N.K. Bracken* .   
*Department of Biological Sciences, University of Central 
Lancashire, Preston and #Department of Physiology, 
FMHS, United Arab Emirates University, Al Ain, UAE 
Defective cardiac function is a frequent complication of 
human diabetes and volatile anaesthetics such as halothane 
can exert a potent negative inotropic effect in the heart.  
This study investigated the effects of halothane (0.6 mM) on 
contraction and on calcium transport in ventricular 
myocytes from streptozotocin (STZ)-induced diabetic rats 
compared with age-matched controls.  STZ (60 mg kg-1) 
was administered intraperitoneally (I.P) to adult male 
Wistar rats, which were humanely killed 8 weeks later.  
Both contraction and Ca2+ transport were measured by 
established techniques (Howarth, F.C & Levi, A.J. (1998) 
Pfluges Arch. 435, 687-698).  The amplitude of contraction 
as a percentage of resting cell length was significantly 
(P<0.01) altered in STZ-induced diabetic myocytes (6.8+ 
0.5%, n=32) than that of control (4.1+ 1.04%, n=27).  The 
tpk of contraction was significantly (P<0.01) longer in 
diabetic myocytes (164.1 + 7.4 ms, n=30 Vs. 132.3 + 5.9 
ms, n=27) compared to control. Halothane evoked 
significant (P<0.05) reductions in the amplitude of 
contraction in control and STZ-induced myocytes compared 
to the responses in the absence of halothane for each.  The 
amplitude of ICa,L was significantly (P<0.05) decreased in 
diabetic myocytes (-0.32 + 0.03 nA, n =7 Vs. 0.66 + 0.05 
nA, n=8) compared to control at +10 mV, respectively.  
Halothane also reduced the peak ICa,L to levels in control 
myocytes similar to the reduction in ICa,L seen in diabetic 
cells.  Basal cytosolic Ca2+ (ratio units) was significantly 
(P<0.01) increased in diabetic myocytes compared to 
control (0.599 + 0.009, n=23, Vs. 0.521 + 0.012 ratio units, 
n=23), respectively.  Electrically stimulated cardiac 
myocytes (1 Hz) induced Ca2+ transients that had a longer 
time from the peak (tpk) of Ca2+ transient to half decay (t½ 
relax).  Halothane, evoked significantly (P<0.05) decreases in 
the Ca2+ transients in control and STZ-induced myocytes 
compared to the responses obtained in the absence of 
halothane.  The results indicate that halothane is exerting its 
negative inotopic effects by reducing cellular Ca2+ 
homeostasis. 
 
The outcome of abnormal glucose tolerance states in 
Central Lancashire 
 
Abdul Lakhdar, 
Lancashire Teaching Hospitals NHS Trust, Preston, UK. 
 
The diagnostic criteria for diabetes mellitus and glucose 
intolerance has recently been redefined.  The American 
Diabetic Association (ADA) advocated the use of fasting 
plasma glucose (FPG) alone, defining diabetes by a fasting 
plasma glucose concentration of 7.0 mmol/l and                   
de-emphasising the oral glucose tolerance test (OGTT).  
The WHO new criteria coincided with the ADA 
recommendation of the use of OGTT if the casual plasma 
glucose concentration is in the uncertain range of 5.5-11.1 
mmol/l.  The OGTT identifies individuals who have a 
diabetic post-challenge blood glucose, but a non-diabetic 
fasting value.  Previous epidemiological studies have shown 
a high prevalence of isolated post-challenge hyperglycaemia 
in association with increased mortality risk.   
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We studied 2769 serial subjects referred with suspected 
diabetes mellitus (median age 35 years, range 15-94 years) 
referred over a 3 year period to the Royal Preston Hospital 
from primary care with suspected diabetes and subjected to 
a glucose tolerance test.   
 
The prevalence of diabetes was similar according to WHO-
1985 and ADA-1997 criteria at 11%. The rate of impaired 
glucose homeostasis was 12% according to the WHO-1985 
and 10% according to the ADA-1997.   
 
906 (33%) individuals showed misclassification.  Out of 
298 (11%) diabetic individuals by WHO-1985 and 295 
(11%) by ADA-1997, only 198 (7%) were diabetic by both 
criteria.  Out of 335 (12%) impaired glucose intolerant 
individuals by WHO-1985 and 273 (10%) impaired fasting 
glucose individuals by ADA-1997 criteria, only 97 (4%) 
had impaired glucose homeostasis by both criteria.  203 
(7%) individuals had abnormal glucose tolerance by WHO-
1985 criteria (168 IGT and 35 DM), had NFG by ADA-
1997.   
 
Although the ADA-1997 and WHO-1985 criteria for the 
diagnosis of diabetes gave a similar rate of diabetes and 
impaired glucose homeostasis, a substantial 
misclassification of individuals results by comparing the 
two criteria. Of most concern is the ADA-1997 criteria 
misses 32% of individuals diagnosed with abnormal glucose 
tolerance according to 2-H PG level. They would have been 
missed by a screening strategy based on a single fasting 
plasma glucose alone. 
 
The new WHO criteria identified all individuals with 
abnormal glucose homeostasis identified by WHO-1985 or 
ADA-1997 criteria.  However, compared with WHO-1985, 
reclassification occurred in 208 individuals. 
 
1471 patients of the original cohort were followed up for a 
median time of 5 years (maximum 8 years) to study 
mortality and glucose tolerance.  Information about survival 
and the cause of death was obtained from the NHS central 
register (The Office for National Statistics).  42% of this 
selected group were males. The median age (at time of 
OGTT) is 51.5 years. The females tend to be younger than 
the males with a median age of 42.1 years compared to 56.4 
years.  Out of 1471 patients, 101 (7.4%) died.  In 47 patients 
(3.2%) death was caused by CVD.  In total, 46% had an 
abnormal glucose level. Among those with higher glucose 
levels, IGT and CH (compared fasting and post-challenge 
hyperglycaemia) are the largest groups with 14% and 13% 
respectively. They are followed by IFH (isolated fasting 
hyperglycaemia), IPH (isolated post-challenge 
hyperglycaemia) and IFG with about 6% each.   
 
 
Effect of impaired glucose tolerance and diabetes on  
mortality 
 
The normal and impaired glucose tolerance groups have 
similar survival rates within each age/gender group.  
Whereas one would expect a worse outcome in the diabetes 
patients, the survival in older men (older than 60 years) with 
DM seems to be better than in the older men with NGT or 
IGT.  In contrast, the outcome seems to be worse for 
diabetic women than non-diabetic. The women survival is 
better than for men. 
 
Effect of fasting and post-challenge hyperglycaemia on  
mortality 
 
The reduced mortality in older male diabetic patients 
compared to those with normal or impaired glucose 
tolerance is apparent in all 3 abnormal glucose tolerance 
groups (IFH, IPH and CH) compared to older male patients 
with normal or impaired glucose tolerance.  In women older 
than 60 years, the increased mortality in the older diabetic 
patients is mainly in the IPH group. Survival of older 
women appeared to be similar in all other groups, while in 
younger women there are only very few events in total. 
 
The survival for diabetic older men appears to be better than 
for older men with normal or impaired glucose tolerance.  
Potential explanations for this phenomena should be 
explored. Apart from men older than 60 years, diabetes is a 
risk factor for all cause mortality with a hazard ratio of 
about 2 and for CVD mortality with a hazard ratio of about 
4.  In women, IPH is associated with a significant increase 
is all cause mortality. 
 
These results have implications for the use of fasting 
hyperglycaemia as an acceptable screening test for diabetes. 
 
The modern management of glycaemia in type 2 
diabetes and the need to treat to target 
 
Abdul Lakhdar, 
Lancashire Teaching Hospitals NHS Trust, Preston, UK. 
 
 
The modern management of type 2 diabetes should start 
with prevention.  Lifestyle changes based around diet and 
exercise have been shown over 4-5 years to reduce the 
progression of impaired glucose tolerance to type 2 diabetes 
by 52%.  However, to translate trials data to a public health 
prospective is difficult and challenging.  There is a case for 
the use of drugs such as the Glitazones and Metformin in 
the prevention of diabetes among high risk groups, along 
with lifestyle measures. 
 
The prevalence of type 2 diabetes is escalating worldwide, 
resulting in a huge cost implication to treat the condition 
and its complications.    Recent publications have provided 
new foundations for the management of people with type 2 
diabetes;  these are Clinical Guidelines and Evidence 
Review for Type 2 Diabetes:  Management of Blood 
Glucose  produced by the National Institute for Clinical 
Excellence, and the National Framework for Diabetes 
Standards and Delivery Strategy produced by the 
Department of Health.  There is a consensus to maintain 
treatment targets of haemoglobin A1c level <7%, fasting 
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plasma glucose ≤6.0 mmol/l, blood pressure <140/80 
mmHg, total cholesterol <4.8 mmol/l, HDL cholesterol >1.2 
mmol/l and triglycerides <1.7 mmol/l. 
 
The traditional first line treatment of type 2 diabetes 
involving diet and weight reduction and exercise are rarely 
sufficient in the long-term and eventually most patients 
require drug treatment to control their glucose levels.   
 
Monotherapy with a single oral hypoglycaemic agent is 
usually effective at maintaining glycaemic control for a few 
years as highlighted in the UKPDS, showing haemoglobin 
A1c levels declined in the first year of monotherapy with 
either Metformin or a Sulphonylurea.  About 50% of 
patients will require more than one pharmacological agent 3 
years after diagnosis, and by 9 years after diagnosis 75% of 
patients will require combination therapy to maintain 
plasma glucose and haemoglobin A1c values at acceptable 
levels. 
 
The natural history of type 2 diabetes involving an 
underlying insulin resistance and progressive deterioration 
in pancreatic beta cell function present in almost all patients 
with type 2 diabetes, explains the progressive loss of 
glycaemic control in type 2 diabetes.  Insulin resistance is 
associated with several cardiovascular risk factors: 
hyperglycaemia, hypertension and dyslipidaemia are 
established associations.  Targeting insulin resistance in the 
management of type 2 diabetes is of relevance. 
 
The choice of a first-line agent should be Metformin in 
overweight patients and also in patients who are not 
overweight.  If Metformin is contra-indicated or not 
tolerated, a Sulphonylurea should be used as a first-line 
agent.  If glycaemic control is not achieved a second agent 
should be added to either Metformin or a Sulphonylurea.  
Depending on the first-line agent, an insulin sensitiser, 
Sulphonylurea or a post-prandial glucose regulator could be 
used.  At this stage the addition of an agent that improves 
insulin sensitivity is of rational choice for patients with 
inadequate control on monotherapy, targeting the underling 
insulin resistance and progressive beta cell dysfunction 
using combination therapy agents. 
 
If glycaemic control is not achieved within 6 months as 
evidenced with haemoglobin A1c levels maintained over 
7%, the next step is triple therapy with the addition of 
another oral hypoglycaemic agent with different mode of 
action or conversion to insulin.  The combination of insulin 
treatment with Metformin is common practice and 
occasionally insulin is combined with Sulphonylureas. 
 
Overwhelming evidence supports tight glycaemic control, 
reduces the risk of complications related to diabetes and a 
target haemoglobin A1c of <7% is a goal to achieve.  Initial 
management of type 2 diabetes with diet and lifestyle 
changes is rarely sufficient in the long-term and 
consideration should be given to pharmacotherapy at an 
earlier stage to attain the haemoglobin A1c level targets. 
Regular review of patients allows review of medication, 
education and regular change of therapy.  Most patients 
with type 2 diabetes will need combination therapy to 
achieve target haemoglobin A1c level as there is often 
progressive loss of glycaemic control due to an underlying 
insulin resistance and progressive pancreatic beta cell 
dysfunction. 
 
However, current drugs available for the management of 
type 2 diabetes are not ideal, but the correct use of these 
drugs, initially alone and later in combination, can improve 
glycaemic control. 
 
The short and long-term effects of diabetic education at 
preston 
 
Binu Krishnan, Wendy Heckels, Sue Lea and A. Lakhdar 
Lancashire Teaching Hospitals NHS Trust, Preston, UK. 
 
The aim of this study was to explore the effect of a single 
episode of one to one diabetic and dietetic education on 
short and long-term glycaemic control. Patients and 
Methods: We studied 42 diabetic individuals with poor 
glycaemic control (Haemoglobin A1c level >7.5%) 
identified at diabetic annual review.  39 subjects were 
followed up for 1 year.  All patients attended a one to one 
session of diabetic and dietetic education with the diabetes 
nurse specialist and specialist diabetes dietician, covering 
various aspects of diabetic and dietetic education.Patients’ 
mean age was 52.46 ± 13.47 years (range 19-77 years).  20 
were males. Body mass index mean 28.46 ± 5.73.  
Haemoglobin A1c level measured at zero,  6.4 ± 2.1 and 
13.4 ± 2.9 months. 24 patients had a change in therapy 
while medication dose was adjusted in all patients. Results: 
Mean haemoglobin A1c level dropped from 9.2 ± 1.3% at 
baseline to 8.0 ± 1.5% (p<0.05) and to 8.3 ± 1.2% at 12 
months (p<0.005) in all patients.  In comparison with 
females, male patients sustained improvement in glycaemic 
control up to 12 months with haemoglobin A1c level at 9.1 
± 1.2% at baseline, 7.8 ± 1.3% at 6 months and 7.8 ± 1.8% 
at 12 months (p<0.05) comparing with female levels of 9.4 
±1.4% at baseline, 8.3 ± 1.7% at 6 months and 9.1 ± 2% at 
12 months.  The pattern of haemoglobin A1c level change 
was not affected with alteration of treatment, race or initial 
haemoglobin A1c level. Conclusions: A single episode of 
one to one diabetic and dietetic education improved 
glycaemic control at 6 months, with a trend towards 
improvement at 1 year.  Men responded better than women 
to educational strategies, suggesting a gender difference in 
response to educational intervention.  These results 
reinforce the role of diabetic education as an important 
strategy in the management of patients with diabetes. 
 
Mechanisms underlying contractile dysfunction in type I  
induced diabetic cardiomyopathy 
Thomas Netticadan  
Institute of Cardiovascular Sciences, St. Boniface Hospital  
Research Centre, Canada 
 
Contractile dysfunction is a feature of type I diabetic hearts. 
Because the sarcoplasmic reticulum (SR) plays a central 
role in cardiac contractility we examined the hypothesis that 
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abnormal SR function and it regulation contribute to 
contractile dysfunction in diabetic hearts. Diabetes was 
induced in male Sprague-Dawley rats by an injection of 
streptozotocin (65 mg/kg i.v.), and the animals were 
sacrificed 6 weeks later for assessment of cardiac 
performance and SR function. Cardiac performance was 
depressed in diabetic animals and this decline was 
associated with a reduction in SR Ca2+-uptake and -release 
activities.  Reduced SR function was consistent with a 
significant decrease in the level of SR Ca2+-cycling 
proteins, such as ryanodine receptor and Ca2+-pump 
ATPase and a decrease in the ratio of protein content of 
Ca2+-pump ATPase to phospholamban. On the other hand, 
the calcium-calmodulin dependent protein kinase (CaMK) 
and cyclic AMP dependent protein kinase 
(PKA)phosphorylation of SR Ca2+-cycling proteins, the 
endogenous SR CaMK and PKA activities, and the 
endogenous SR phosphatase activities were increased in the 
diabetic heart. Treatment of 3-week diabetic animals with 
insulin partially or fully prevented the diabetes-induced 
changes in cardiac performance, SR Ca2+-uptake and -
release activities, and SR protein content, whereas the 
diabetes-induced changes in SR CaMK- and PKA-mediated 
phosphorylations and activities, as well as phosphatase 
activities, were not significantly affected. These results 
suggest that the reduced content of SR Ca2+-cycling 
proteins appear to be a major defect underlying SR 
dysfunction and impaired contractility in the type I diabetic 
heart.   
 
Management of type 2 Diabetes mellitus (NIDDM) 
amongst ethnic groups in the north west: is the level of 
help and information distributed to patients from ethnic 
minorities adequate to meet their individual needs? 
 
H. Kauser 
University of Central Lancashire, Department of Biological 
Sciences 
 
Diabetes is one of the most common chronic diseases. There 
are striking differences in its frequency between racial 
groups. Type 2 diabetes (NIDDM) accounts for 90% of all 
diabetes and it is more common with increasing age, obesity 
and in certain ethnic groups, affecting 1 in 3 Asians over 65 
years of age. 
 
In principle their management is the same but they pose 
special problems of culture, religion, diet as well as 
communication. The aim of the study was to determine how 
well Type 2 diabetes is managed among ethnic groups in 
certain areas in the North West. The main question in 
research was ‘Is the level of help available to the Asian 
diabetic adequate to meet their own individual needs and 
does it take into consideration cultural, religious and 
communicational barriers to treatment?’ 
 
30 questionnaires and 10 semi-structured interviews were 
conducted and completed by Asian diabetes attending 
diabetic clinics around certain towns in the North West. 
Questionnaires were available in English, Urdu/Punjabi, 
Hindi, Gujrati and Bengali. Interviews were conducted on 
one-to-one basis in English and Urdu (answers were 
translated into English ready for analysis). 
 
Results from the questionnaires, showed that 40% of the 
participants could speak and understand English fluently. 60 
% could not and required an interpreter to be able to 
communicate with their diabetic care team. 70% of the 
participants were on tablets and control of diet as part of 
their treatment for diabetes, 20% on diet alone and 10% on 
insulin injections. 70% of the participants did attend 
diabetic clinics however 30% did not. It was also found that 
only 40% of the participants received information packs 
about diabetes, its causes, management and control in a 
language that they fully understood, 60% did not and had to 
rely on family members to educate them and translate any 
information they received. 40% of the participants claimed 
that they found the conventional diet sheets available from 
the diabetic health teams useful, however 60% did not find, 
because their normal dietary habits differed to the ones 
mentioned on the conventional dietary sheets. 20% of the 
participants were satisfied with the level of help available to 
the Asian diabetics, 20% were not and 60% stated that the 
system has room for improvement. 
 
Results from the interviews showed that 7 of the 10 
participants could not speak English fluently. 50% of the 
patients received information packs and diabetes, its causes 
and management in a language that they understood for 
example in Urdu. 50% did not and stated that they were 
unaware that teaching aids such as videos and cassettes 
were available from their diabetic health teams in a 
language they could understand. It was also found that all of 
the 10 participants only attended their appointments at the 
diabetic clinics if a member of family who could understand 
and speak English fluently went with them, as they 
themselves could not communicate with the diabetic health 
teams. Finally all of the 10 participants expressed that a 
better understanding of cultures, religions and normal Asian 
dietary habits is required on the behalf of diabetic health 
professionals in order to improve the levels of help that they 
receive. 
 
To conclude, an understanding of cultural, religious and 
dietary practices is prerequisite for giving correct advice to 
the Asian patient. Appropriate teaching methods, effective 
educational material and reliable, sensitive and confidential 
interpreter service are few of the areas which still need to be 
carefully explored if diabetes amongst ethnic minorities is 
to be managed and controlled effectively. 
 
 
 
 
   
 
